xiaodong wu
Shanghai Proton and Heavy Ion Center (SPHIC)
Shanghai, China
Review Editor
Pharmacology of Anti-Cancer Drugs
Editors
Shanghai Proton and Heavy Ion Center (SPHIC)
Shanghai, China
Review Editor
Pharmacology of Anti-Cancer Drugs
Targeted Tracer Research and Development Laboratory, Department of Respiratory and Critical Care Medicine, West China Hospital, Sichuan University
Chengdu, China
Review Editor
Pharmacology of Anti-Cancer Drugs
St. John's University
Queens, United States
Review Editor
Pharmacology of Anti-Cancer Drugs
German Cancer Research Center (DKFZ)
Heidelberg, Germany
Review Editor
Pharmacology of Anti-Cancer Drugs
The Affiliated Hospital of Jinggangshan University
Ji'an, China
Review Editor
Pharmacology of Anti-Cancer Drugs
School of Medicine, Shanghai Jiao Tong University
Shanghai, China
Review Editor
Pharmacology of Anti-Cancer Drugs
Huazhong University of Science and Technology
Wuhan, China
Review Editor
Pharmacology of Anti-Cancer Drugs
Liaoning University of Traditional Chinese Medicine
Shenyang, China
Review Editor
Pharmacology of Anti-Cancer Drugs
ReNAgade Therapeutics
Cambridge, United States
Review Editor
Pharmacology of Anti-Cancer Drugs
Dalian University of Technology
Dalian, China
Review Editor
Pharmacology of Anti-Cancer Drugs
Fudan University
Shanghai, China
Review Editor
Pharmacology of Anti-Cancer Drugs
Liaoning University
Shenyang, China
Review Editor
Pharmacology of Anti-Cancer Drugs
School of Pharmacy, Liaoning University of Traditional Chinese Medicine
Da Lian, China
Review Editor
Pharmacology of Anti-Cancer Drugs
University of Vigo
Vigo, Spain
Review Editor
Pharmacology of Anti-Cancer Drugs
Yunnan Cancer Hospital
Kunming, China
Review Editor
Pharmacology of Anti-Cancer Drugs
University of Florida
Gainesville, United States
Review Editor
Pharmacology of Anti-Cancer Drugs